CV protection by SGLT2 inhibition: Potential mechanisms for benefit
Disclosures
Prof. Hiddo Lambers Heerspink - Department of Clinical Pharmacology, University Medical Center Groningen, The Netherlands
Prof. Hiddo Lambers Heerspink - Department of Clinical Pharmacology, University Medical Center Groningen, The Netherlands
Share this page with your colleagues and friends: